VIENNA, April 8 – RIA Novosti. The European Union should buy the Russian Sputnik V vaccine after a corresponding audit by the European Medicines Agency (EMA), said former European Commission head Jean-Claude Juncker.
“When EMA checks Sputnik V, we should buy this vaccine. The virus knows no boundaries. The origin of the vaccines does not matter, and if the drug is effective, then it should be used when it becomes available,” Juncker said on the Austrian ORF TV channel. …
The former head of the European Commission noted that “COVID-19 is not a toy,” and one cannot refuse the vaccine due to the fact that it was produced in Russia.
The Russian vaccine against the Sputnik V coronavirus has been undergoing a gradual examination procedure since March 4 at the European Medicines Agency EMA, which is engaged in the approval of vaccines for use on the European market. Earlier in the EMA expressed hope that the assessment of “Sputnik V” will be held in an accelerated period, but there is no date for the approval of the vaccine. According to media reports, the approval of the Russian vaccine, if there are no difficulties, should be expected in May.
The Sputnik V vaccine has been approved in nearly 60 countries with a total population of over 1.5 billion. Sputnik V ranks second in the world in terms of the number of approvals received by government regulators. The vaccine efficacy at 91.6% is confirmed by the publication of data in the leading medical journal The Lancet.